Dosteril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dosteril

Property Description
Active Ingredients Tramadol hydrochloride, Paracetamol
Form Oral Tablet
Pharmacological Class Combination Analgesic (Opioid / Non-Opioid)
General Purpose Management of moderate to severe pain
Origin Synthetic

Dosteril is a prescription medication classified as a combination analgesic, used for the management of pain categorized as moderate to severe. Because of its specific components, Dosteril is strictly controlled and requires authorization from a healthcare professional, placing it in the Rx (prescription-only) category.


Identity and Composition

Dosteril is defined by its two primary active ingredients: Tramadol hydrochloride and Paracetamol (also known as Acetaminophen). This makes it a fixed-dose combination drug, a specific type of formulation where both pain relievers are pre-measured into a single tablet. The active agents are synthetic in origin.

Tramadol functions as an opioid analgesic, while Paracetamol is a non-opioid pain reliever. The strategic combination of these two agents is clinically recognized for achieving synergistic pain relief, meaning the therapeutic benefit is greater than that of either ingredient used alone. This combination strategy is a key differentiating factor, often used when single-agent treatments fail.


General Therapeutic Purpose

The general purpose of Dosteril is to provide effective relief for pain that has not been adequately addressed by standard, single-ingredient painkillers. The dual-action formula allows the medication to influence the body’s pain perception through two different pharmacological pathways simultaneously.

The medication targets pain by modulating the body's response both centrally and peripherally. This confirms that Dosteril offers a comprehensive, two-pronged strategy for pain management when pain is severe enough to warrant the use of a controlled substance but requires the complementary relief offered by the non-opioid component.

What side effects are possible with Dosteril?

Dosteril: Possible Side Effects and Safety Information

Official regulatory information emphasizes that this combination product, containing Tramadol (an opioid) and Paracetamol, carries significant safety risks, most notably those associated with opioid use. The most frequently reported adverse reactions are generally non-serious, but serious and potentially fatal adverse events have been documented.

Adverse Reaction Categories

Classification Examples of Reactions (by System-Organ Class)
Very Common (Affects >1 in 10) Nausea, Dizziness, Somnolence (Drowsiness), Constipation, Pruritus (Itching).
Common (Affects ≤1 in 10) Vomiting, Headache, Sweating, Dry mouth, Diarrhea, Confusion, Sleep disorders.
Uncommon (Affects ≤1 in 100) Increase in pulse/blood pressure, Heart rate disorders, Tingling/Numbness, Depression, Hallucinations, Serotonin Syndrome.

Serious Warnings and Safety Restrictions

Official labeling includes specific Boxed Warnings regarding risks of Addiction, Abuse, and Misuse, which can lead to overdose and death. A primary serious risk is Life-Threatening Respiratory Depression (slowed or stopped breathing), particularly upon initiation or dosage increase. Concomitant use with alcohol or other central nervous system (CNS) depressants (e.g., benzodiazepines) is explicitly warned against due to the risk of profound sedation, respiratory depression, and coma.

Population-Specific Contraindications: The medication is contraindicated in children younger than 12 years of age. It is also contraindicated for post-operative pain management in children and adolescents younger than 18 years of age following tonsillectomy and/or adenoidectomy. Prolonged use during pregnancy can result in Neonatal Opioid Withdrawal Syndrome in newborns. Additionally, caution is required in elderly patients, those with a history of seizures (as the drug may lower the seizure threshold), and those with severe liver or kidney impairment, which may necessitate dosage adjustment or restriction.

Liver Toxicity: Due to the Paracetamol component, exceeding the maximum recommended daily dose or concurrent use of other Paracetamol-containing products can result in serious, potentially fatal, liver toxicity.

Overdose and Emergency Response

Any suspected overdose of Dosteril requires immediate medical attention, regardless of the initial presence of symptoms. Regulatory guidance mandates urgent referral to a specialized unit for comprehensive management.

The official overdose profile reflects the dual toxicity of its active components, Tramadol and Paracetamol, affecting multiple physiological systems. The Tramadol component is associated with severe Central Nervous System (CNS) depression, leading to manifestations like miosis, seizures, and the life-threatening risk of respiratory arrest or cardiopulmonary collapse. The Paracetamol component primarily carries the risk of systemic toxicity, resulting in early signs such as pallor and vomiting, followed by severe, potentially fatal hepatic failure and acute renal damage. Liver damage is explicitly possible following ingestion of 7.5–10 grams or more of Paracetamol.

Due to this dual risk, management protocols require measuring plasma concentrations of both substances and utilizing the Paracetamol overdose nomogram. Specific antidotes are documented: Naloxone is available to manage opioid-induced respiratory depression, and N-acetylcysteine (NAC) is indicated for Paracetamol toxicity. Supportive measures, including gastric lavage and activated charcoal, may be described. Overdose is noted as a particular concern for young children and patients with non-cirrhotic alcoholic liver disease.

Therapeutic Uses of Dosteril

What Dosteril Treats: Main Uses and Benefits

Dosteril is used for managing moderate to severe pain symptoms in situations where patient symptoms are inadequately managed by standard, single-ingredient analgesics alone. The medicine is commonly applied in clinical settings that involve acute or unstable symptom patterns.

The medicine is relevant for easing symptoms that may include pain associated with postoperative pain, discomfort linked to acute traumatic injuries, and providing supportive relief for persistent symptoms in chronic pain conditions. The combination is considered relevant across domains where additional symptomatic support is needed.

“The primary goal supports the patient during difficult episodes by easing distress and contributes to comfort during periods of heightened symptoms.”

This combined approach provides supportive relief when symptoms interfere with routine activities by easing the symptoms that interfere with daily functioning, and may help patients cope more steadily with symptom fluctuations during recovery phases.


Quick Fact: Relief for Moderate to Severe Pain

The medication is relevant when symptoms related to physical discomfort create noticeable physiological strain, applied across domains where additional symptomatic support is needed when symptoms are inadequately managed by standard non-opioid treatments.

Eligibility and Restrictions for Use

Dosteril, a combination analgesic, is strictly governed by regulatory eligibility rules defined by health authorities. The medicine is allowed for use in adults and adolescents aged 12 years and over whose moderate to severe pain requires this specific fixed-dose combination.

Absolute Contraindications

Use is contraindicated and must be strictly avoided in several populations and clinical states:

  • Age and Procedure: All children younger than 12 years of age are excluded. It is also forbidden for patients under 18 years for post-operative pain relief after tonsillectomy or adenoidectomy.
  • Organ and Comorbidity: Patients with severe hepatic impairment (severe liver disease), uncontrolled epilepsy, or those in a state of acute intoxication (e.g., alcohol, opioids, hypnotics) are prohibited from using this medicine.
  • Concurrent Medication: Use is contraindicated in patients concurrently receiving Monoamine Oxidase Inhibitors (MAOIs).

Restrictions and Limitations

Eligibility is limited by organ function and physiological states:

  • Pregnancy and Lactation: Use is not recommended during both pregnancy and breastfeeding.
  • Severe Organ Impairment: The medicine is not recommended for patients with severe renal insufficiency or severe respiratory insufficiency.
  • Older Adults: Patients over 75 years may require an extended interval between doses due to changes in drug clearance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes documented drug interactions for Dosteril, a combination product containing paracetamol and tramadol, based on official regulatory information.


Contraindicated Combinations

Dosteril must not be used concurrently with Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of discontinuing their use. The product is also contraindicated with any other medication containing tramadol or paracetamol to prevent accidental overdose.

Clinically Significant Interactions

The most significant interactions involve substances affecting the central nervous system (CNS) or those metabolized by specific liver enzymes.

Interaction Category Interacting Substances/Classes Interaction Result
CNS Depressants Benzodiazepines, general anesthetics, alcohol Increased risk of profound sedation and respiratory depression.
Serotonergic Agents SSRIs, SNRIs, TCAs, Triptans Increased risk of Serotonin Syndrome.
Hepatic Metabolism CYP2D6 or CYP3A4 Inhibitors/Inducers (e.g., Quinidine, Carbamazepine) Altered concentration of tramadol and its active metabolite.
Anticoagulants Warfarin and other coumarin derivatives Potential for clinically relevant changes in INR values.

Special Population Considerations

Official labeling includes warnings for individuals classified as CYP2D6 Ultra-Rapid Metabolizers, who face a heightened risk of adverse effects due to rapid conversion of tramadol into its active metabolite.

Mechanism of Action

Dual Central Modulation of Pain Signaling

The Tramadol component acts through a dual molecular mechanism involving the central nervous system ( CNS). Its active metabolite primarily functions as an agonist at the mu-opioid receptor (mu-OR), which reduces the excitability of neurons that transmit signals. Concurrently, Tramadol inhibits the reuptake of norepinephrine and serotonin in the spinal cord, which functionally enhances the body's descending pain inhibitory pathways. This combination results in a central reduction of nociceptive signal transmission.

Central Pathway Adjustments via Enzyme Modulation

The Paracetamol component modulates the synthesis of chemical mediators that regulate central nerve sensitization. It works primarily in the CNS by inhibiting certain Cyclooxygenase ( COX) isoforms, which limits the formation of prostaglandins. Limiting their central synthesis modulates the overall excitability threshold of central pain pathways. This action is specific to the CNS and interacts with the pathways modulated by Tramadol.

Mechanistic Synergy and Metabolic Constraint

The combination exhibits functional synergy, where the simultaneous modulation of two separate inhibitory pathways results in a non-additive alteration of signal processing. The degree of Tramadol's mu-opioid modulation is subject to a physiological constraint, as it relies on metabolic conversion by the polymorphic CYP2 D6 enzyme.

Dosage and Administration Information

Dosteril is administered exclusively via the oral route as a fixed-dose combination tablet containing Tramadol 37.5 mg and Paracetamol 325 mg. The medication is intended for short-term use, generally limited to a course duration of not more than five days.

The standard adult starting regimen is an initial dose of two tablets. Subsequent doses are taken on an as-needed (PRN) basis, but the schedule mandates a minimum interval of no less than four to six hours between successive administrations. It is critical that the maximum daily dose of eight tablets (equivalent to 300 mg Tramadol and 2600 mg Paracetamol) is not exceeded within any 24-hour period.

For proper administration, the tablets must be swallowed whole with a sufficient quantity of liquid and are not to be broken, crushed, or chewed. They may be taken independently of meal times. A key administrative restriction is the prohibition of concomitant use with any other medicinal product containing either Tramadol or Paracetamol to prevent accidental overdose.

Dosing adjustments are required for specific populations. For patients with severe renal impairment (creatinine clearance < 30 mL/min), the dose must be reduced, with a maximum of two tablets every 12 hours. For older adults (over 75 years), the dosing interval may require extension due to potential changes in the elimination rate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dosteril

This overview summarizes the type of clinical research conducted for the fixed-dose combination of tramadol and paracetamol, focusing on what was studied and what remains uncertain, based on official regulatory and scientific literature.


Evidence for use in Acute Moderate to Severe Pain

Research examined the combination in conditions that involve acute symptom patterns, such as pain following surgery or traumatic injury. Researchers primarily conducted short-term Randomized Controlled Trials (RCTs) to examine how symptoms change over time. These studies included adults experiencing heightened symptom activity after procedures like dental extraction or other minor surgeries. Researchers in the trials examined outcomes related to physical discomfort, primarily monitoring the immediate change in pain intensity and the time until patients needed to take an additional pain medication.

Studies report how changes in symptoms were measured in the observed populations during periods of increased symptom activity. Some trials described patterns where the dual-agent combination's findings were observed to differ when compared to either tramadol alone or paracetamol alone when used in a single-dose administration. Long-term outcomes following a single course of treatment for an acute episode are not well characterized.

Evidence for use in Chronic Non-Cancer Pain

The combination was studied for conditions characterized by functional limitations and where symptoms may vary in intensity, such as chronic low back pain or symptomatic osteoarthritis of the knee and hip. Research explored outcomes related to daily functioning or activity level over defined time intervals, usually for up to three months. These trials included adults whose pain was not adequately managed by standard non-opioid treatments alone.

Studies monitored patterns related to measured changes in functional measures and reported discomfort when the combination was observed compared to placebo. Long-term outcomes are not fully established, as follow-up durations were typically limited to intermediate periods.


Research Gaps and What is Still Uncertain

Key limitations in the evidence base include the short follow-up durations in many core efficacy trials, meaning long-term effects are not fully established. Comparative evidence against some newer pain management strategies is also lacking in some areas. Data for certain subgroups, particularly pediatric patients and those with complex comorbidities, remains limited.

Key Studies & References Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (National Academies of Sciences, Engineering, and Medicine)

Frequently Asked Questions (FAQ)

Common questions about Dosteril (FAQ)

Q: What is the main difference between Dosteril and other common medicines used for the same thing?

A: Official information states that Dosteril is a fixed-dose combination product, meaning it contains two active pain-relieving ingredients: an opioid analgesic (Tramadol) and a non-opioid analgesic (Paracetamol). This dual approach is often used for pain that was not adequately relieved by standard non-opioid treatments alone, reflecting its two distinct mechanisms.

Q: Does Dosteril start working right away, or does it take a few weeks?

A: Studies and official information indicate that Dosteril is intended for use in acute symptom patterns, such as pain following surgery. Clinical studies assessed outcomes related to the immediate change in pain intensity after administration. This suggests the medication is expected to have a rapid onset of action, measured in hours rather than weeks.

Q: Is there any known interaction between Dosteril and common over-the-counter pain relievers?

A: Official product information contraindicates the use of Dosteril with any other product containing Paracetamol (Acetaminophen) or Tramadol to strictly prevent accidental overdose. Due to this safety restriction, it is important that any use of medications with the same ingredients be avoided.

Q: Are there any specific foods or drinks that should be avoided when taking Dosteril?

A: Regulatory documents state that use with alcohol is associated with a severely increased risk of extreme drowsiness and dangerous respiratory depression. The tablets may be taken independently of meal times, and official product information does not typically specify avoiding common foods.

Q: Where can I find the official regulatory documents or studies on Dosteril?

A: Authoritative drug information is published by governmental agencies like the FDA and EMA. Regulatory details such as the FDA Prescribing Information (Label) and the Summary of Product Characteristics (SmPC) are available on the respective governmental websites.

Q: Is Dosteril associated with any warnings related to driving or operating machinery?

A: Dosteril has common side effects including dizziness, somnolence (drowsiness), and confusion. The presence of these effects suggests potential impairment in the ability to drive or operate machinery, as noted in regulatory materials.

Q: Is Dosteril available in different strengths or forms?

A: According to the official product composition, Dosteril is manufactured and prescribed as a fixed-dose combination oral tablet. It contains 37.5 mg of Tramadol and 325 mg of Paracetamol in this single form, and regulatory documents do not specify alternative forms or strengths.

Q: What is the meaning of the high-level safety classification (e.g., Schedule X) for Dosteril?

A: Dosteril is classified as a controlled substance (typically Schedule IV) because it contains the opioid Tramadol. This classification, as determined by regulatory bodies, indicates that the medicine has a recognized potential for abuse and dependence, which necessitates strict control over its manufacture, storage, and prescription.

Q: If I miss a dose of Dosteril, what is the generally accepted advice?

A: Official administration instructions mandate a minimum interval of no less than four to six hours between doses taken as needed. Due to the risks associated with the opioid and paracetamol components, one key regulatory caution mentioned is that doses should not be doubled to compensate for a missed administration.

Q: Does Dosteril require regular monitoring or blood tests?

A: Regulatory information indicates that patients with severe hepatic (liver) impairment or severe renal (kidney) impairment require special consideration and dosage adjustments. These conditions indicate a potential need for prior or subsequent assessment of organ function.

Q: If I take other prescription drugs, how is the interaction risk with Dosteril determined?

A: Regulatory documents detail that interaction risk is largely determined by how other substances affect the central nervous system (CNS) or the body's metabolism. Specifically, agents that increase sedation, those that affect serotonin levels, or those that alter the function of the CYP2D6/CYP3A4 liver enzymes may change how Dosteril works or increase its potential for adverse effects.

Q: How quickly can Dosteril be discontinued?

A: Dosteril is intended for short-term use for acute pain, and discontinuation is typically manageable after a brief course. If the medication is used for longer periods, abrupt discontinuation of the opioid component can result in serious withdrawal symptoms. The need for a gradual dosage reduction (taper) may be indicated.

Q: Can Dosteril affect laboratory test results?

A: Official product information notes that Dosteril may affect the results of certain laboratory tests. Specifically, when Dosteril is taken with the anticoagulant Warfarin, it can cause clinically relevant changes in INR values, a laboratory measure of how quickly blood clots.

How should Dosteril be stored and disposed of?

How to Store and Dispose of Dosteril?

Because Dosteril contains the opioid tramadol, mandatory regulations apply to its storage and disposal to prevent misuse and ensure stability.

Requirement Area Official Labeling Statements
Storage Conditions Store below 25 C or 30 C in a dry place. Protect from moisture, light, and excessive heat. Do not refrigerate or freeze.
Child Safety Keep this medicine out of the sight and reach of children. Store securely in a locked cabinet or location due to its controlled substance classification.
Packaging Keep the tablets in the original container and blister pack until the time of use. Do not use past the expiration date.
Disposal Instructions Return unused or expired medicine to an official drug take-back location or pharmacy. If no take-back option is available, dispose of the medicine in household trash by mixing it with an unappealing substance (e.g., used coffee grounds) and sealing the mixture in a bag. Do not dispose of in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dosteril found in:

A-Z Index: